India's largest online dental-commerce and technology platform selling consumables, equipment and instruments to dentists, with an in-house dental lab (Smileworks) and digital case-management tools.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 0 | 0 | 13 | 16 | 17 | 17 | 17 |
| Reserves | 0 | 0 | 6 | 3 | 52 | 116 | 154 | 157 |
| Borrowings | 1 | 2 | 3 | 1 | 0 | 0 | 0 | 0 |
| Other Liabilities | 4 | 4 | 10 | 11 | 17 | 17 | 19 | 21 |
| Total Liabilities | 5 | 7 | 19 | 28 | 86 | 150 | 190 | 196 |
| AssetsFixed Assets | 0 | 0 | 1 | 2 | 2 | 15 | 22 | 23 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 12 | 44 | 52 | 45 |
| Other Assets | 4 | 6 | 18 | 26 | 70 | 86 | 116 | 128 |
| Total Assets | 5 | 7 | 19 | 28 | 86 | 150 | 190 | 196 |
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 1 | 0 | 0 | 2 | -11 | -5 | -27 |
| Cash from Investing | 0 | -1 | 0 | -1 | -22 | -42 | -4 |
| Cash from Financing | 0 | 1 | 1 | 0 | 36 | 47 | 30 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — |
| Free Cash Flow | 0 | -1 | 0 | 0 | -14 | -23 | -31 |
| FCF Margin | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (62.1×) and current (69.6×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -21.6% growth and a 62× exit, ₹377 only delivers your return if you pay ₹37. The price is currently baking in 20% growth.
EPS grows -21.6%/yr for 5 years, then fades to 6% over 2, exits at 62×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -21.6% | 4.25 |
| FY28 | -21.6% | 3.33 |
| FY29 | -21.6% | 2.61 |
| FY30 | -21.6% | 2.05 |
| FY31 | -21.6% | 1.61 |
| FY32 | -7.8% ·fade | 1.48 |
| FY33 | 6.0% ·fade | 1.57 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.